Abstract
BP is defined as the tension in the blood vessel wall, resulting from blood flow through the lumen. Normal BP, one of the main parameters of cardiovascular function, reflects the ability of blood to reach the vascular bed of the organs; abnormal BP may cause serious complications. BP regards arteries, veins, and lymphatics alike, and abnormalities may consist either in excessive increase (HTN) or decrease (hypotension).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Guidelines
The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension Eur Heart J. 2007;28:1462-1536.
Suggested Reading
Jamerson K, Weber MA, Bakris GL, et al.; for the ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428.
Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24(1):135-146.
Feldstein C. Management of hypertensive crises. Am J Ther. 2007;14(2):135-139.
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2003;43:239-246.
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
Julius S, Kjeldsen SE, Weber M, et al.; VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022-2031.
Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865-872.
Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with variousantihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534-2544.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensinconverting enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardialinfarction, and stroke in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this chapter
Cite this chapter
Adelmann, G.A. (2010). Disorders of Blood Pressure. In: Cardiology Essentials in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84996-305-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-84996-305-3_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-304-6
Online ISBN: 978-1-84996-305-3
eBook Packages: MedicineMedicine (R0)